Bacteriophage Therapy Market: By Type (Lytic, Lysogenic), By Application (Diagnostic, Antimicrobial Drug Discovery, Veterinary Medicines, Others), By End-User (Hospitals & Clinics, Academic Research Organizations & Institutes, Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Bacteriophage Therapy Market Size was valued at USD 1,242.0 million in 2022 and is poised to grow at a CAGR of 3.5% from 2023-2029. Phages, also called bacteriophages are viruses that attack and target bacteria exclusively. They're one of the most frequent biological entities capable of fighting and killing multi-drug resistance bacteria. When all other antibiotics have failed to treat an illness, phages are able to eliminate the bacteria that are causing the infectious disease, allowing medical practitioners to save a life. Bacteriophages are being looked at as a possible antibiotic option. Viruses are utilized in this therapy to insert their genetic material into bacteria and grow using their host machinery. This phage therapy is utilized in the body of patients to treat or prevent bacterial illnesses.

Bacteriophage therapy is also important in the disciplines of molecular biology and technological research. These characteristics broaden the possibility of medication development. Significant research and development activities in the bacteriophage therapy market are supporting the industry's expansion. For example, the United States Food and Drug Administration acknowledged an Investigational New Drug application from health professionals at the University of California San Diego School of Medicine in January 2019 to perform the first U.S. clinical trial of a bacteriophage-based medication intravenous administration. The planned experiment will be carried out in partnership with AmpliPhi Biosciences Corporation, a biotechnology firm based in San Diego. As per the World Health Organization, about 550 million people (almost one out of every ten people on the planet) will become ill and 430,000 will die as a result of contaminated food in 2019, resulting in the loss of 34 million healthy life years (DALYs). Additionally, the COVID-19 pandemic is posing significant challenges to companies in the worldwide bacteriophage therapy market on multiple fronts. The source of raw materials for creating medication inventions is a serious concern because to transport facility variations. Also, owing to a rise in several patients suffering from Coronavirus and other lethal conditions, goods distributors are seeing erratic demand from retailers.  

Bacteriophage Therapy Market Key Developments:

In January 2018, Pherecydes Pharma raised US$ 10.3 Mn Series B funding led by GO CAPITAL, ACE Management, and Auriga Partners to enter the clinical trials novel bacteriophages PHOSA for the treatment of  Staphylococcus aureus infection and PNEUMOPHAGE for the treatment of Pseudomonas aeruginosa respiratory tract infections.

 

Bacteriophage Therapy Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

3.5%

Largest Market

Asia-Pacific

Fastest Growing Market

North-America
Bacteriophage Therapy Market Dynamics

An increase in the incidence of antibiotic-resistant bacteria strengthens the use of bacteriophage therapy. Moreover, FDA approval for bacteriophage therapies, stringent regulations for the use of antibiotics, promising pipeline drugs under various stages of clinical trials, rise in funding from the public and private sector for bacteriophage therapy research, and a wide range of applications with bacteriophage therapeutics are propelled the bacteriophage therapy market over the forecast years. Bacteriophage therapy or phage therapy is used to treat pathogenic bacterial infections with viruses. These are more specific than bacteria and do not cause any harm to host organisms as well as beneficial bacteria such as gut flora. Bacteriophages are most abundant in the biosphere and isolated, concentrated, and applied in specific areas to eradicate the bacteria. They cause the bacterium to lyse by disrupting the bacterial metabolism. The major advantages of bacteriophages over antibiotics include being very specific, replicating at the site of infection, fewer side effects, and rapidly selecting the new phages. Bacteriophages can be administered by oral, rectal, intravenous, intrapleural injections, and local applications.

Key Features of the Reports

  • The bacteriophage therapy market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Bacteriophage Therapy Market Segmentation

By Type
  • Lytic
  • Lysogenic
By Application
  • Diagnostic
  • Antimicrobial Drug Discovery
  • Veterinary Medicines
  • Others
By End-User
  • Hospitals & Clinics
  • Academic Research Organizations & Institutes
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The bacteriophage therapy market key players are Armata Pharmaceuticals Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Phagelux, Nextbiotics

1.Executive Summary
2.Global Bacteriophage Therapy Market Introduction 
2.1.Global Bacteriophage Therapy Market  - Taxonomy
2.2.Global Bacteriophage Therapy Market  - Definitions
2.2.1. By Type
2.2.2. By Application
2.2.3. By End User
2.2.4. By Region
3.Global Bacteriophage Therapy Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Bacteriophage Therapy Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Bacteriophage Therapy Market  By Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Lytic
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Lysogenic
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Bacteriophage Therapy Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Diagnostic
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Antimicrobial Drug Discovery
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Veterinary Medicines
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Bacteriophage Therapy Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospitals & Clinics
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Academic Research Organizations & Institutes
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Bacteriophage Therapy Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Bacteriophage Therapy Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Lytic
9.1.2.Lysogenic
9.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Diagnostic
9.2.2.Antimicrobial Drug Discovery
9.2.3.Veterinary Medicines
9.2.4.Others
9.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals & Clinics
9.3.2.Academic Research Organizations & Institutes
9.3.3.Others
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Bacteriophage Therapy Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Lytic
10.1.2.Lysogenic
10.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Diagnostic
10.2.2.Antimicrobial Drug Discovery
10.2.3.Veterinary Medicines
10.2.4.Others
10.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals & Clinics
10.3.2.Academic Research Organizations & Institutes
10.3.3.Others
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Bacteriophage Therapy Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Lytic
11.1.2.Lysogenic
11.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Diagnostic
11.2.2.Antimicrobial Drug Discovery
11.2.3.Veterinary Medicines
11.2.4.Others
11.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals & Clinics
11.3.2.Academic Research Organizations & Institutes
11.3.3.Others
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Bacteriophage Therapy Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Lytic
12.1.2.Lysogenic
12.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Diagnostic
12.2.2.Antimicrobial Drug Discovery
12.2.3.Veterinary Medicines
12.2.4.Others
12.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals & Clinics
12.3.2.Academic Research Organizations & Institutes
12.3.3.Others
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Bacteriophage Therapy Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Lytic
13.1.2.Lysogenic
13.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Diagnostic
13.2.2.Antimicrobial Drug Discovery
13.2.3.Veterinary Medicines
13.2.4.Others
13.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals & Clinics
13.3.2.Academic Research Organizations & Institutes
13.3.3.Others
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Armata Pharmaceuticals Inc.
14.2.2.Eliava Biopreparations Ltd.
14.2.3.Pherecydes Pharma
14.2.4.Intralytix
14.2.5.Phagelux
14.2.6.Nextbiotics
14.2.7.InnoPhage
14.2.8.Locus Biosciences
14.2.9. TechnoPhage
14.2.10. Eligo Bioscience SA
14.2.11. Phagomed Biopharma GmbH.
14.2.12. PhagePro
15. Research Methodology 
16. Appendix and Abbreviations 
  • Armata Pharmaceuticals Inc.
  • Eliava Biopreparations Ltd.
  • Pherecydes Pharma
  • Intralytix
  • Phagelux
  • Nextbiotics
  • InnoPhage
  • Locus Biosciences
  •  TechnoPhage
  •  Eligo Bioscience SA
  •  Phagomed Biopharma GmbH.
  •  PhagePro
  •  Adaptive Phage Therapeutics
  •  Enbiotix.

Adjacent Markets